通过抑制线粒体新陈代谢缓解瘤复发:一种新的NIR激光诱导的治疗策略
Yao Liu1, Zujun Que1, Tianqi An1
1Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, No. 274 Zhijiang Middle Road, Shanghai, 200071, China.
Biological procedures online
|July 3, 2025
概括
这项研究提出了一个新的纳米平台,通过抑制线粒体代谢,使用光热疗法和提供化疗来打击瘤复发. 这种方法有效地抑制了瘤的生长,并提高了治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 瘤复发是癌症治疗中的一个主要挑战,通常是由线粒体超代谢驱动的.
- 异常的癌细胞能量代谢有助于治疗耐药性和疾病进展.
研究的目的:
- 开发一种用于癌症治疗的多功能纳米平台.
- 结合线粒体代谢抑制,光热疗法和化疗来克服瘤复发.
主要方法:
- 通过分子自组装工程化生物降解的多多巴胺纳米粒子 (PDA-DOX-CO NPs).
- 与多克索鲁比辛 (DOX) 和一氧化碳 (CO) 前药一起加载的纳米粒子.
- 研究的协同疗效包括光热剥离,CO介导的线粒体抑制和受控的DOX释放.
主要成果:
- 在近红外 (NIR) 辐射下,PDA-DOX-CO NPs在48.38°C的瘤高温下实现了瘤高温.
- 已证明的协同效应:光热剥离,通过CO抑制线粒体,以及精确的DOX输送.
- 在HCT-116瘤模型中实现了60%的瘤完全消去.
- 组织病理学证实了显著的亡和改变的线粒体形态.
结论:
- 开发的纳米平台提供了一个协同作用的"代谢封锁+能量耗尽+精确传递"战略.
- 这种多模式的方法有效地准瘤复发机制.
- 通过针对线粒体的作用,证明了增强的治疗疗效和生物安全性.
相关概念视频
Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


